SEM · As filed with the SEC
Select Medical Holdings balance sheet, by quarter
The statement as Select Medical Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Balance Sheets (unaudited) · USD thousands
| USD thousands | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets: | ||||
| Cash and cash equivalents | 25,683 | 26,523 | 60,054 | 52,349 |
| Accounts receivable | 949,480 | 864,207 | 825,811 | 909,460 |
| Prepaid income taxes | 12,412 | 19,622 | 10,719 | 7,223 |
| Other current assets | 124,522 | 114,929 | 123,880 | 111,858 |
| Total Current Assets | 1,112,097 | 1,025,281 | 1,020,464 | 1,080,890 |
| Operating lease right-of-use assets | 1,042,220 | 957,904 | 939,083 | 938,624 |
| Property and equipment, net | — | — | 903,242 | 921,741 |
| Property and equipment, net | 997,409 | 992,314 | — | — |
| Goodwill | 2,378,179 | 2,360,902 | 2,333,143 | 2,331,898 |
| Identifiable intangible assets, net | 99,864 | 100,800 | 101,425 | 101,925 |
| Other assets | 412,314 | 414,388 | 388,366 | 367,172 |
| Total Assets | 6,042,083 | 5,851,589 | 5,685,723 | 5,742,250 |
| LIABILITIES AND EQUITY | ||||
| Current Liabilities: | ||||
| Overdrafts | 19,394 | 16,751 | 0 | 16,506 |
| Current operating lease liabilities | 179,449 | 188,405 | 184,215 | 182,150 |
| Current portion of long-term debt and notes payable | 25,185 | 24,217 | 28,778 | 20,326 |
| Accounts payable | 166,467 | 157,063 | 167,102 | 163,265 |
| Accrued and other liabilities | 579,870 | 598,058 | 559,483 | 556,743 |
| Total Current Liabilities | 970,365 | 984,494 | 939,578 | 938,990 |
| Non-current operating lease liabilities | 931,195 | 835,362 | 818,586 | 818,128 |
| Long-term debt, net of current portion | 1,835,523 | 1,803,979 | 1,743,371 | 1,839,631 |
| Non-current deferred tax liability | 117,862 | 112,157 | 88,311 | 72,946 |
| Other non-current liabilities | 81,197 | 79,858 | 76,021 | 73,293 |
| Total Liabilities | 3,936,142 | 3,815,850 | 3,665,867 | 3,742,988 |
| Redeemable non-controlling interests | 20,967 | 18,808 | 8,651 | 8,493 |
| Stockholders’ Equity: | ||||
| Common stock, $0.001 par value, 700,000,000 shares authorized, 124,017,191 and 124,016,800 shares issued and outstanding at 2025 and 2026, respectively | 124 | 124 | 124 | 123 |
| Capital in excess of par | 889,055 | 874,848 | 870,575 | 867,347 |
| Retained earnings | 872,222 | 837,016 | 824,813 | 804,728 |
| Accumulated other comprehensive loss | (5,380) | (6,404) | (6,242) | (5,157) |
| Total Stockholders’ Equity | 1,756,021 | 1,705,584 | 1,689,270 | 1,667,041 |
| Non-controlling interests | 328,953 | 311,347 | 321,935 | 323,728 |
| Total Equity | 2,084,974 | 2,016,931 | 2,011,205 | 1,990,769 |
| Total Liabilities and Equity | 6,042,083 | 5,851,589 | 5,685,723 | 5,742,250 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.